Artificial Intelligence: Applications in Ophthalmology. Part 1
https://doi.org/10.18008/1816-5095-2026-1-14-21
Abstract
Artificial intelligence (AI) is becoming an integral part of modern medical technologies, especially in the field of disease diagnostics.
In recent years, its application in ophthalmology has become broader, and it affects an increasing number of nosologies.
This review article covers the issues of AI terminology, historical aspects of the use of AI in medicine in general and in ophthalmology in particular, and highlights modern achievements and scientific developments in this field.
The future of AI in ophthalmology and the prospects for the development are discussed. Ophthalmologists, researchers, and artificial intelligence experts are the target audience for this article.
About the Authors
A. O. Ukina
Gatchina Interdistrict Clinical Hospital
Russian Federation
Russian Federation
Ukina Anastasiia O., ophthalmologist
Roshchinskaya str., 15а, bld. 1, Gatchina, Leningrad region, 188300
E. B. Myakoshina
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Myakoshina Elena B., MD, senior research officer of Ophthalmology and Radiology Department
Sadovaya-Chernogryazskaya str., 14/19, Moscow, 105062
References
1. Federal Agency for Technical Regulation and Metrology. Artificial intelligence. Concepts and terminology of artificial intelligence. Moscow: Federal Agency for Technical Regulation and Metrology; 2024 (In Russ.). URL: https://docs.cntd.ru/document/1310068314 (аccessed 07.01.2025).
2. Deep learning. Neurocomputer technologies (In Russ.). URL: https://neerc.ifmo. ru/wiki/index.php?title=Глубокое_обучение (Accessed: 07.01.2025).
3. Order of Rosstandart dated October 28, 2024 No. 1542‑st. Moscow: Federal Agency for Technical Regulation and Metrology, 2024 (In Russ.). URL: https://www.consultant.ru/document/cons_doc_LAW_490595/(accessed 07.01.2025).
4. Morhat PM. To the question of definition of the concept of artificial intelligence. Law and State: Theory and Practice. 2017;2(156):25–32 (In Russ.).
5. McCarthy J Minsky ML, Rochester N, Shannon CE. A Proposal for the Dartmouth Summer Research Project on Artificial Intelligence, August 31, 1955. AI Magazine. 2006;27(4):12. doi: 10.1609/aimag.v27i4.1904.
6. Voznyuk PA. The history of development and the current state of artificial intelligence. Globe: Technical Sciences. 2019;5(3(27)):11–19 (In Russ.).
7. Gusev AV, Dobridnyuk SL. Artificial intelligence in medicine and healthcare. Information Society. 2017;4–5:78–93 (In Russ.).
8. Poryaeva EP, Evstafieva VA. Artificial intelligence in medicine. Vestnik nauki i obrazovaniya. 2019;60(6‑2):15–18 (In Russ.).
9. Rodríguez Corral JM, Civit‑Masot J, Luna‑Perejón F, Díaz‑Cano I, Morgado‑Estévez A, Domínguez‑Morales M. Energy efficiency in edge TPU vs. embedded GPU for computer‑aided medical imaging segmentation and classification. Engineering Applications of Artificial Intelligence. 2024;127:107298. doi: 10.1016/j.engappai.2023.107298.
10. Melle WV. MYCIN: a knowledge‑based consultation program for infectious disease diagnosis. International Journal of Human‑computer Studies /International Journal of Man‑machine Studies. 1978;10:313–322.
11. Wolfram DA. An appraisal of INTERNIST‑I. Artificial intelligence in medicine, 1995;7(2), 93–116. doi: 10.1016/0933‑3657(94)00028‑q.
12. Dee CR. The development of the Medical Literature Analysis and Retrieval System (MEDLARS). Journal of the Medical Library Association: JMLA. 2007;95(4):416– 425. doi: 10.3163/1536‑5050.95.4.416.
13. Lee K, Kim J. Artificial Intelligence Technology Trends and IBM Watson References in the Medical Field. Korean Medical Education Review. 2016;18(2):51–57. doi: 10.17496/KMER.2016.18.2.51.
14. Tokatl, N, Bilmez Y, Göztepeli G, Güler M, Karan F, Altun H. MelanoTech: Development of a mobile application infrastructure for melanoma cancer diagnosis based on artificial intelligence technologies. 2024 8th International Artificial Intelligence and Data Processing Symposium (IDAP).2024;1:1–6. doi: 10.1109/IDAP64064.2024.10710812.
15. Patel RH, Foltz EA, Witkowski A, Ludzik J. Analysis of Artificial Intelligence‑Based Approaches Applied to Non‑Invasive Imaging for Early Detection of Melanoma: A Systematic Review. Cancers. 2023;15(19):4694. doi: 10.3390/cancers15194694.
16. Marchetti MA, Cowen EA, Kurtansky NR, Weber J, Dauscher M, DeFazio J, Deng L, Dusza SW, Haliasos H, Halpern AC, Hosein S, Nazir ZH, Marghoob AA, Quigley EA, Salvador T, Rotemberg VM. Prospective validation of dermoscopy‑based opensource artificial intelligence for melanoma diagnosis (PROVE‑AI study). NPJ Digit Med. 2023 Jul 12;6(1):127. doi: 10.1038/s41746‑023‑00872‑1.
17. Weiss SM, Kulikowski CA, Safir A. A Model‑Based Consultation System for the Long‑Term Management of Glaucoma. IJCAI. 1977;5: 826–832.
18. Mamedova SS, Karimova AI, Galieva AF, Malkhanova MA, Polyankina SS, Kuchumova AI, Tarasova YaYa, Tsuan DU, Klets OV, Gerbutova VN, Olenichev AV, Ushakova EO, Minnikhalilova AK. The role of artificial intelligence in modern ophthalmology. Ophthalmology Reports. 2024;17(1):103–113 (In Russ.). doi: 10.17816/OV625627.
19. Neroev VV, Zaytseva OV, Petrov SYu, Bragin AA. Artificial intelligence in ophthalmology: the present and the future. Russian Ophthalmological Journal. 2024;17(2):135–141 (In Russ.). doi: 10.21516/2072‑0076‑2024‑17‑2‑135‑141.
20. Anton N, Doroftei B, Curteanu S, Catãlin L, Ilie OD, Târcoveanu F, Bogdănici CM. Comprehensive Review on the Use of Artificial Intelligence in Ophthalmology and Future Research Directions. Diagnostics (Basel). 2022 Dec 29;13(1):100. doi: 10.3390/diagnostics13010100.
21. Dorofeev DA, Poleva RP, Vitkov AA, Asinovskova II, Semenov ED. Diagnosis and monitoring of glaucoma using artificial intelligence. Мodern technologies in ophthalmology. 2024;54(2):161 (In Russ.). doi: 10.25276/2312‑4911‑2024‑2‑161‑162.
22. Kuroedov AV, Ostapenko GA, Mitroshina KV, Movsisyan AB. State of the art of glaucoma diagnosis: neural networks and artifi al intelligence. Clinical ophthalmology. 2019;19(4):230–237 (In Russ.). doi: 10.32364/2311‑7729‑2019‑19‑4‑230‑237.
23. Movsisyan AB, Kuroedov AV, Ostapenko GA, Podvigin SV, Rachinsky YuA. Using neural networks and artificial intelligence as a modern method for diagnosing glaucoma. Modern technologies in ophthalmology. 2020;3:27–28 (In Russ.). doi: 10.25276/2312‑4911‑2020‑3‑27‑28.
24. Komarovskikh EN, Podtynnykh EV. Using artificial neural networks for early diagnosis of glaucoma. Russian Ophthalmological Journal. 2023;16(2):28–32 (In Russ.). doi: 10.21516/2072‑0076‑2023‑16‑2‑28‑32.
25. Dorofeev DA, Kazanova SYu, Movsisyan AB, Poleva RP. Artificial intelligence and neural networks in the diagnosis of glaucoma. National Journal glaucoma. 2023;22(1):115–128 (In Russ.). doi: 10.53432/2078‑4104‑2023‑22‑1‑115‑128.
26. Kunumpol P, Lerthirunvibul N, Phienphanich P, Munthuli A, Temahivong K, Tantisevi V, Manassakorn A, Chansangpetch S, Itthipanichpong R, Ratanawongphaibul K, Rojanapongpun P, Tantibundhit C. GlauCUTU: Time Until Perceived Virtual Reality Perimetry With Humphrey Field Analyzer Prediction‑Based Artificial Intelligence. IEEE Access. 2022;10:36949–36962.
27. Gunasekeran DV, Ting DSW, Tan GSW, Wong TY. Artificial intelligence for diabetic retinopathy screening, prediction and management. Curr Opin Ophthalmol. 2020 Sep;31(5):357–365. doi: 10.1097/ICU.0000000000000693.
28. Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, Ting DSW. Artificial intelligence for diabetic retinopathy screening: a review. Eye (Lond). 2020 Mar;34(3):451–460. doi: 10.1038/s41433‑019‑0566‑0. Epub 2019 Sep 5. Erratum in: Eye (Lond). 2020 Mar;34(3):604. doi: 10.1038/s41433‑019‑0728‑0.
29. Vilela, LFC, Cabral NO, Destefani AC, Destefani VC. Нarnessing the power of artificial intelligence for early detection and management of diabetic retinopathy, agerelated macular degeneration, and glaucoma: a narrative review of deep learning applications in ophthalmology. Revista Ibero‑Americana De Humanidades, Ciências E Educação, 2024;10(8):3311–3320. doi: 10.51891/rease.v10i8.15395.
30. Kulikov AN, Malahova EYu, Maltsev DS. Artificial intelligence and machine learning for optical coherence tomography‑based diagnosis in central serous chorioretinopathy. Ophthalmology Reports 2019;12(1):13–20 (In Russ.). doi: 10.17816/OV2019113‑20.
31. Selvam A, Ong J, Bollepalli SC, Chhablani J, Vupparaboina KK, Driban M. Artificial Intelligence in Choroid Through Optical Coherence Tomography: A Comprehensive Review. 2023; Authorea Preprints.
32. Bhuiyan A, Wong TY, Ting DSW, Govindaiah A, Souied EH, Smith RT. Artificial Intelligence to Stratify Severity of Age‑Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD. Transl Vis Sci Technol. 2020 Apr 24;9(2):25. doi: 10.1167/tvst.9.2.25.
33. Shah S, Slaney E, VerHage E, Chen J, Dias R, Abdelmalik B, Weaver A, Neu J. Application of Artifi al Intelligence in the Early Detection of Retinopathy of Prematurity: Review of the Literature. Neonatology. 2023;120(5):558–565. doi: 10.1159/000531441.
34. Malyugin BE, Sakhnov SN, Axenova LE, Myasnikova VV. Application of artificial intelligence in diagnostics and surgery of keratoconus: a systematic overview. Fyodorov Journal of Ophthalmic Surgery. 2022;1:77–96 (In Russ.). doi: 10.25276/02354160‑2022‑1‑77‑96
35. Shukhaev SV, Mordovtseva EA, Pustozerov EA, Kudlakhmedov SS. Application of convolutional neural networks to define Fuchs endothelial dystrophy. Fyodorov Journal of Ophthalmic Surgery. 2022;4S:70–76 (In Russ.). doi: 10.25276/0235‑41602022‑4S‑70‑76.
36. Carmona González D, Palomino Bautista C. Accuracy of a new intraocular lens power calculation method based on artifi al intelligence. Eye (Lond). 2021 Feb;35(2): 517–522. doi: 10.1038/s41433‑020‑0883‑3.
37. Sakhnov SN, Axenov KD, Axenova LE, Vronskaya VV, Martsinkevich AO, Myasnikova VV. Development of a cataract screening model using an open dataset and deep machine learning algorithms. Fyodorov Journal of Ophthalmic Surgery. 2022;4S:13–20 (In Russ.). doi: 10.25276/0235‑4160‑2022‑4S‑13‑20.
38. Kazachanskaya MYu, Gordienko PR, Goncharov IO, Shreiner BA. Evelopment of a Mobile Computer Vision Application to Help the Visually Impaired. Digital transformation and artificial intelligence in education. 2021:141–145 (In Russ.).
39. Khan R, Surya J, Roy M, Swathi Priya, MN, Mohan S, Raman S, Raman A, Vyas A, Raman R. Use of artificial intelligence algorithms to predict systemic diseases from retinal images. Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2023;13(5):e1506.
40. Omar MO, Abad Ali, MJ, Qabillie SE, Haji AI, Takriti MB, Atif AH, Rangraze I. Beyond Vision: Potential Role of AI‑enabled Ocular Scans in the Prediction of Aging and Systemic Disorders. Siriraj Medical Journal. 2024;76(2):106–115. doi: 10.33192/smj.v76i2.266303.
41. Chuprov AD, Bolodurina IP, Lositskiy AO, Zhigalov AYu. Organizing follow‑up care for patients with macular retinal pathologies using artificial intelligence systems. Digital Diagnostics. 2024;5(1):75–84 (In Russ.). doi: 10.17816/DD623956.
42. Farahat Z, Zrira N, Souissi N, Bennani Y, Bencherif S, Benamar S, Belmekki M, Ngote MN, Megdiche K. Diabetic retinopathy screening through artificial intelligence algorithms: A systematic review. Surv Ophthalmol. 2024 Sep‑Oct;69(5):707–721. doi: 10.1016/j.survophthal.2024.05.008.
43. Peris‑Martínez C, Shaha A, Clarida W, Amelon R, Hernáez‑Ortega MC, Navea A, Morales‑Olivas J, Dolz‑Marco R, Pérez‑Jordá P, Verbraak F, Heijden AAV. Use in clinical practice of an automated screening method of diabetic retinopathy that can be derived using a diagnostic artifi al intelligence system. Arch Soc Esp Oftalmol (Engl. Ed). 2021 Mar;96(3):117–126. English, Spanish. doi: 10.1016/j.oftal.2020.08.007.
44. Vought R, Vought V, Shah M, Szirth B, Bhagat N. EyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events. Int Ophthalmol. 2023 Dec; 43(12):4851–4859. doi: 10.1007/s10792‑023‑02887‑9.
45. Registration certificate for a medical device RZN 2024/23001. Software for working with digital medical images in the diagnosis of ophthalmological pathologies by analyzing photographs of the fundus and scans of structural OCT Retina.AI according to TU 58.29.32‑001‑60003594‑2022. Moscow: Federal Service for Surveillance in Healthcare (Roszdravnadzor), 2024. URL: https://nevacert.ru/reestry/med-reestr/rzn-202423001-77069 (accessed: 07.01.2025).
46. Katalevskaya EA, Sizov AYu, Tyurikov MI, Vladimirova YuV. Artifi al intelligence algorithms for the diagnosis of signs of diabetic retinopathy, diabetic macular edema, age‑related macular degeneration, vitreomacular interface abnormalities. Fyodorov Journal of Ophthalmic Surgery. 2022;4S:58–69 (In Russ.). doi: 10.25276/0235‑41602022‑4S‑58‑69.
47. Neroev VV, Bragin AA, Zaytseva OV. Diagnostics of retinal pathologies by optical coherence tomography images using artificial intelligence tools. Russian Ophthalmological Journal. 2023;16(3):47–53 (In Russ.). doi: 10.21516/2072‑0076‑2023‑163‑47‑53.
Review
For citations:
Ukina A.O., Myakoshina E.B. Artificial Intelligence: Applications in Ophthalmology. Part 1. Ophthalmology in Russia. 2026;23(1):14-21. (In Russ.) https://doi.org/10.18008/1816-5095-2026-1-14-21
Views:
407
JATS XML
Email this article 